Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sayan Chatterjee

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
ACS Pharmacology & Translational Science|January 19, 2023
Neuroprotective Effect of Swertiamarin in a Rotenone Model of Parkinson's Disease: Role of Neuroinflammation and Alpha-Synuclein AccumulationMonika Sharma, Fehmina Mushtaque Malim, Ashutosh Goswami, et al.
Malaria Journal|October 18, 2021
Purification of native histidine-rich protein 2 (nHRP2) from Plasmodium falciparum culture supernatant, infected RBCs, and parasite lysateBalwan Singh, Jessica N McCaffery, Amy Kong, et al.
Molecular Neurobiology|September 1, 2022
Chlorogenic Acid: a Polyphenol from Coffee Rendered Neuroprotection Against Rotenone-Induced Parkinson's Disease by GLP-1 SecretionNishant Sharma, Ritu Soni, Monika Sharma, et al.
ACS Pharmacology & Translational Science|March 16, 2023
Association of COVID-19 with Comorbidities: An UpdateSayan Chatterjee, Lakshmi Vineela Nalla, Monika Sharma, et al.
Trials|February 1, 2022
Protocol for ICiCLe-ALL-14 (InPOG-ALL-15-01): a prospective, risk stratified, randomised, multicentre, open label, controlled therapeutic trial for newly diagnosed childhood acute lymphoblastic leukaemia in IndiaNandana Das, Shripad Banavali, Sameer Bakhshi, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
ACS Pharmacology & Translational Science|January 19, 2023
Neuroprotective Effect of Swertiamarin in a Rotenone Model of Parkinson's Disease: Role of Neuroinflammation and Alpha-Synuclein AccumulationMonika Sharma, Fehmina Mushtaque Malim, Ashutosh Goswami, et al.
Malaria Journal|October 18, 2021
Purification of native histidine-rich protein 2 (nHRP2) from Plasmodium falciparum culture supernatant, infected RBCs, and parasite lysateBalwan Singh, Jessica N McCaffery, Amy Kong, et al.
Molecular Neurobiology|September 1, 2022
Chlorogenic Acid: a Polyphenol from Coffee Rendered Neuroprotection Against Rotenone-Induced Parkinson's Disease by GLP-1 SecretionNishant Sharma, Ritu Soni, Monika Sharma, et al.
ACS Pharmacology & Translational Science|March 16, 2023
Association of COVID-19 with Comorbidities: An UpdateSayan Chatterjee, Lakshmi Vineela Nalla, Monika Sharma, et al.
Trials|February 1, 2022
Protocol for ICiCLe-ALL-14 (InPOG-ALL-15-01): a prospective, risk stratified, randomised, multicentre, open label, controlled therapeutic trial for newly diagnosed childhood acute lymphoblastic leukaemia in IndiaNandana Das, Shripad Banavali, Sameer Bakhshi, et al.
Pageof 3